Lung oncology Clinical Trials in Fort Worth, TX
As of August 2026, 17 paid clinical trials are recruiting for Lung oncology in Fort Worth, Texas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
17 clinical trials for Lung oncology
·Clear filters·Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Top Research Study Locations in Fort Worth
Researchers run research studies in Fort Worth, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cook Children's Medical Center | B Acute Lymphoblastic Leukemia, Cystic Fibrosis, Malignant Solid Neoplasm | 52 |
| UT Southwestern/Simmons Cancer Center-Fort Worth | Stage IVB Prostate Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8, Endometrial Clear Cell Adenocarcinoma | 28 |
| Cook Children's Health Care System | Langerhans Cell Histiocytosis, Anesthesia, Catheter-Related Infections | 10 |
| Re:Cognition Health - Fort Worth | Alzheimers Disease, Chronic Pain, Osteoarthritis, Knee | 8 |
| Cook Children's Hospital | Duchenne Muscular Dystrophy, Hodgkin Lymphoma, ALL | 6 |
| JPS Health Network | Asthma, Asthma Attack, Asthma Exacerbations | 5 |
| Texas Christian University | Criminal Behavior, Dementia, Drug Overdose | 5 |
| Baylor All Saints Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 4 |
| GI Alliance - Fort Worth | Metabolic Dysfunction-Associated Steatotic Liver Disease, Moderately to Severely Active Crohns Disease, Ulcerative Colitis | 4 |
| GSK Investigational Site | Liver Diseases, Alcoholic, Multiple Myeloma, Neoplasms, Head and Neck | 4 |
| John Peter Smith Hospital | Drug-Related Side Effects and Adverse Reactions, Esophageal Squamous Cell Carcinoma, Nausea | 4 |
| START Dallas | Advanced Malignancies, Cancer, G12D Mutated KRAS | 4 |
| START Dallas Fort Worth | Adenocarcinoma of Esophagus, Advanced Breast Cancer, Advanced Ovarian Cancer | 4 |
| Texas Oncology - DFW | Advanced Non-Small Cell Lung Cancer, Advanced Solid Tumor, Breast Cancer | 4 |
| Cook Children's | Hematopoietic Cell Transplant, Hemoglobinopathies, Respiratory Viral Infection | 4 |
| START Dallas Fort Worth, LLC | Castration-resistant Prostate Cancer, Castration-resistant Prostate Cancer (CRPC), Colorectal Cancer | 3 |
| Tarrant County Hospital District/JPS Health Network | Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma | 3 |
| The Center for Cancer and Blood Disorders | Anemia, Carcinoma, Non-Small-Cell Lung, Myelodysplastic Syndrome | 3 |
| University of North Texas Health Science Center | Chronic Low Back Pain, Hypertension, Memory Impairment | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Baylor Scott & White All Saints Medical Center - Fort Worth | Cancer, Hepatitis | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Contact Alcon Call Center for Trial Locations | Ocular Hyperemia | 2 |
| Cook Children's Endocrinology | Hypochondroplasia | 2 |
| Cook Children's Medical Center - Fort Worth | Neuroblastoma | 2 |
Active & Upcoming Studies in Fort Worth (2026)
Recruiting trials in Fort Worth grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (121 active studies)
- Gotistobart Long Term Extension (LTE) Study · Phase 3 · OncoC4, Inc.
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer · Phase 2 · Verastem, Inc.
Cardiovascular (20 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Occlutech AFR Fontan Study · Occlutech International AB
Neurology & pain (15 active studies)
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain · Phase 2 · Eli Lilly and Company
- A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Osteoarthritis Pain · Phase 2 · Eli Lilly and Company
Diabetes & metabolic (11 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Efficacy and Safety of Oral KAI-7535 in Adult Participants Living With Obesity or Overweight With at Least 1 Weight-Related Comorbidity · Phase 2 · Kailera
Mental health & behavior (8 active studies)
- Justice Community Overdose Innovation Network II TCU Hub · Texas Christian University
- A Multi-Site Study to Assess the Effect of Availability of a Heated Tobacco Product on Smoking Abstinence Among Current Primary Cigarette Smokers · RAI Services Company
Eye & vision (5 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
Pediatric (4 active studies)
- Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · Cook Children's Health Care System
- KiteLock 4% EDTA Lock Solution for the Prevention of Occlusions in Children With Intestinal Failure · SterileCare Inc.
HIV / STI (1 active study)
- A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) · Phase 2, Phase 3 · Merck Sharp & Dohme LLC
Common conditions studied in Fort Worth
- Endometrial Cancer (7 active studies)
- Heart Failure (7 active studies)
- Ovarian Cancer (6 active studies)
- ARDS (5 active studies)
- Acute Respiratory Distress Syndrome (5 active studies)
- Breast Neoplasms (5 active studies)
Leading research sponsors in Fort Worth
- National Cancer Institute (NCI)
- Eli Lilly and Company
- Children's Oncology Group
- Merck Sharp & Dohme LLC
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Fort Worth?
There are approximately 320 recruiting clinical trials in Fort Worth, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fort Worth pay participants?
Most recruiting trials in Fort Worth compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fort Worth?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fort Worth?
The most common conditions under active study in Fort Worth include Endometrial Cancer (7), Heart Failure (7), Ovarian Cancer (6), ARDS (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fort Worth?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fort Worth on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fort Worth?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fort Worth?
Recruiting research sites in Fort Worth include Cook Children's Medical Center, UT Southwestern/Simmons Cancer Center-Fort Worth, Cook Children's Health Care System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fort Worth right now?
The largest active categories in Fort Worth are Cancer & tumors (121), Cardiovascular (20), Neurology & pain (15). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.